Jean‐Frédéric Boyer

714 total citations
15 papers, 553 citations indexed

About

Jean‐Frédéric Boyer is a scholar working on Rheumatology, Immunology and Oncology. According to data from OpenAlex, Jean‐Frédéric Boyer has authored 15 papers receiving a total of 553 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Rheumatology, 5 papers in Immunology and 4 papers in Oncology. Recurrent topics in Jean‐Frédéric Boyer's work include Rheumatoid Arthritis Research and Therapies (7 papers), Systemic Lupus Erythematosus Research (6 papers) and Bone health and treatments (2 papers). Jean‐Frédéric Boyer is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (7 papers), Systemic Lupus Erythematosus Research (6 papers) and Bone health and treatments (2 papers). Jean‐Frédéric Boyer collaborates with scholars based in France, Russia and Germany. Jean‐Frédéric Boyer's co-authors include Arnaud Constantin, J. Davignon, Alain Cantagrel, Pierre‐Antoine Gourraud, Benjamin Rauwel, Yannick Degboé, Michel Baron, Adeline Ruyssen‐Witrand, Michel Laroche and A. Cantagrel and has published in prestigious journals such as Journal of Bone and Mineral Research, Frontiers in Immunology and Annals of the Rheumatic Diseases.

In The Last Decade

Jean‐Frédéric Boyer

13 papers receiving 546 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jean‐Frédéric Boyer France 10 323 181 109 64 64 15 553
Edit Végh Hungary 12 257 0.8× 143 0.8× 66 0.6× 63 1.0× 41 0.6× 28 440
Е Н Александрова Russia 11 374 1.2× 161 0.9× 90 0.8× 46 0.7× 60 0.9× 210 610
Vasileios Vazgiourakis Greece 10 200 0.6× 252 1.4× 90 0.8× 45 0.7× 57 0.9× 25 431
Lena Innala Sweden 7 520 1.6× 105 0.6× 74 0.7× 92 1.4× 42 0.7× 11 630
D Logar Slovenia 13 336 1.0× 85 0.5× 63 0.6× 59 0.9× 52 0.8× 17 509
Matt Cravets United States 11 330 1.0× 106 0.6× 135 1.2× 33 0.5× 56 0.9× 17 679
Larissa Lisnevskaia Canada 6 505 1.6× 394 2.2× 111 1.0× 25 0.4× 68 1.1× 8 738
Jenny Amaya‐Amaya Colombia 12 351 1.1× 148 0.8× 49 0.4× 35 0.5× 22 0.3× 21 595
Yonsu Son Japan 16 412 1.3× 264 1.5× 80 0.7× 33 0.5× 55 0.9× 49 712
Spyros N. Nikas Greece 12 335 1.0× 119 0.7× 98 0.9× 28 0.4× 47 0.7× 16 506

Countries citing papers authored by Jean‐Frédéric Boyer

Since Specialization
Citations

This map shows the geographic impact of Jean‐Frédéric Boyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean‐Frédéric Boyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean‐Frédéric Boyer more than expected).

Fields of papers citing papers by Jean‐Frédéric Boyer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jean‐Frédéric Boyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean‐Frédéric Boyer. The network helps show where Jean‐Frédéric Boyer may publish in the future.

Co-authorship network of co-authors of Jean‐Frédéric Boyer

This figure shows the co-authorship network connecting the top 25 collaborators of Jean‐Frédéric Boyer. A scholar is included among the top collaborators of Jean‐Frédéric Boyer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jean‐Frédéric Boyer. Jean‐Frédéric Boyer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
2.
Baron, Michel, Yannick Degboé, Jean‐Frédéric Boyer, et al.. (2021). Evidence for tmTNF reverse signaling in vivo: Implications for an arginase-1-mediated therapeutic effect of TNF inhibitors during inflammation. iScience. 24(4). 102331–102331. 7 indexed citations
3.
Rauwel, Benjamin, Michel Baron, Emmanuelle Lacassagne, et al.. (2019). AB0040 JAK INHIBITORS – BARICITINIB AND TOFACITINIB – MODULATE THE IN VITRO INFLAMMATORY AND ALTERNATIVE POLARIZATIONS OF MACROPHAGES. Annals of the Rheumatic Diseases. 78. 1486–1487. 4 indexed citations
4.
Rauwel, Benjamin, Yannick Degboé, Michel Baron, et al.. (2019). Inhibition of Osteoclastogenesis by the RNA-Binding Protein QKI5: a Novel Approach to Protect from Bone Resorption. Journal of Bone and Mineral Research. 35(4). 753–765. 12 indexed citations
5.
Degboé, Yannick, Benjamin Rauwel, Michel Baron, et al.. (2019). Polarization of Rheumatoid Macrophages by TNF Targeting Through an IL-10/STAT3 Mechanism. Frontiers in Immunology. 10. 138 indexed citations
6.
Davignon, J., Benjamin Rauwel, Yannick Degboé, et al.. (2018). Modulation of T-cell responses by anti-tumor necrosis factor treatments in rheumatoid arthritis: a review. Arthritis Research & Therapy. 20(1). 229–229. 45 indexed citations
7.
Boyer, Jean‐Frédéric, Vanina Bongard, A. Cantagrel, et al.. (2012). Link between traditional cardiovascular risk factors and inflammation in patients with early arthritis: Results from a French Multicenter Cohort. Arthritis Care & Research. 64(6). 872–880. 19 indexed citations
8.
Boyer, Jean‐Frédéric, Pierre‐Antoine Gourraud, Alain Cantagrel, J. Davignon, & Arnaud Constantin. (2011). Méta-analyse des facteurs de risque traditionnels cardiovasculaires dans la polyarthrite rhumatoïde. Revue du Rhumatisme. 78(3). 245–250. 1 indexed citations
9.
Boyer, Jean‐Frédéric, Pierre‐Antoine Gourraud, Alain Cantagrel, J. Davignon, & Arnaud Constantin. (2010). Traditional cardiovascular risk factors in rheumatoid arthritis: A meta-analysis. Joint Bone Spine. 78(2). 179–183. 212 indexed citations
10.
Davignon, J., Jean‐Frédéric Boyer, B. Jamard, et al.. (2010). Maintenance of cytomegalovirus-specific CD4pos T-cell response in rheumatoid arthritis patients receiving anti-tumor necrosis factor treatments. Arthritis Research & Therapy. 12(4). R142–R142. 9 indexed citations
11.
Boyer, Jean‐Frédéric, A. Cantagrel, & Arnaud Constantin. (2008). Impact of Traditional Therapies and Biologics on Cardiovascular Diseases in Rheumatoid Arthritis. Current Vascular Pharmacology. 6(3). 218–227. 13 indexed citations
12.
Gourraud, Pierre‐Antoine, Philippe Dieudé, Jean‐Frédéric Boyer, et al.. (2007). A new classification of HLA-DRB1 alleles differentiates predisposing and protective alleles for autoantibody production in rheumatoid arthritis. Arthritis Research & Therapy. 9(2). R27–R27. 32 indexed citations
13.
Gourraud, Pierre‐Antoine, Jean‐Frédéric Boyer, Thomas Barnetche, et al.. (2006). A new classification of HLA–DRB1 alleles differentiates predisposing and protective alleles for rheumatoid arthritis structural severity. Arthritis & Rheumatism. 54(2). 593–599. 36 indexed citations
14.
Laroche, Michel & Jean‐Frédéric Boyer. (2004). Phosphate diabetes, tubular phosphate reabsorption and phosphatonins. Joint Bone Spine. 72(5). 376–381. 24 indexed citations
15.
Laroche, Michel & Jean‐Frédéric Boyer. (2004). Diabètes phosphorés, réabsorption tubulaire du phosphore, phosphatonines. Revue du Rhumatisme. 72(9). 789–795. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026